Who are Roca Therapeutics's investors?

Roca Therapeutics's investors include 3B Future Health Fund.

Where is Roca Therapeutics headquartered?

Roca Therapeutics is headquartered in Nice, FR.

Roca Therapeutics

Nice, FR · 3 known investors

Find your way into Roca Therapeutics

Roca Therapeutics develops first-in-class small molecule therapies for patients with neovascular retinal diseases. Founded in 2021 as a spin-off from Nice University and SATT Sud Est, the company is a biotech focused on ophthalmology drug development based in Nice, France.

Biotech Healthtech Medical Devices

Investors · 3

3B Future Health FundMonaco · $12M

Also in the syndicate · 2

3B Future Health Fund IIleadSATT Sud-Estlead

Funding

SEC filings, press & company announcements

Undisclosed amountseed funding roundSep 2022
3B Future Health Fund II (lead), SATT Sud-Est (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Roca Therapeutics announcing new financing from Provence-Alpes-Côte d'Azur and Massif des Alpes FEDER-FSE+-FTJ 2021-2027 program - Roca Therapeuticsroca-therapeutics.org · May 2025

Roca Therapeutics completes seed funding roundglobenewswire.com · Sep 2022

Frequently asked questions

What does Roca Therapeutics do?: Roca Therapeutics develops first-in-class small molecule therapies for patients with neovascular retinal diseases. Founded in 2021 as a spin-off from Nice University and SATT Sud Est, the company is a biotech focused on ophthalmology drug development based in Nice, France.
Who are Roca Therapeutics's investors?: Roca Therapeutics's investors include 3B Future Health Fund.
Where is Roca Therapeutics headquartered?: Roca Therapeutics is headquartered in Nice, FR.